baber/WOPTO huggingface dataset:
Patent WO-2019168459-A1 (WO)
Inventor: NELEN HANS
IPC: B65D19/38
Filed: 2019-02-26
Abstract: The invention relates to an element (1) to be arranged in a corner of a parallelepipedic cage-like structure where a bottom or a top plane of the structure meets two walls of the structure extending perpendicularly to this plane and to each other. The element (1) comprises a bottom portion (2), outer wall portions (6, 7), inner wall portions (9, 10) and wall members (16, 17) so as to receive components of said structure in the form of first and second board-like members, such as wooden planks, therebetween with wide sides of these board-like members bearing on each other. The inner wall portions (9, 10) each comprises a spring member (90, 100) configured to bear onto and urge a said second board- like member to press a said first board-like member against an outer wall portion (6, 7), so as to clamp these board-like members between a couple of inner (9, 10) and outer (6, 7) wall portions. The invention also relates to a cage-like structure provided with such elements (1) at said corners thereof.
Patent WO-2020122797-A1 (WO)
Title: Conditional mobility
Inventor: DA SILVA ICARO L J
IPC: H04W36/00
Filed: 2019-12-10
Abstract: A method in a first network node is disclosed. The method comprises receiving (402) an indication that a User Equipment, UE, has connected to a second network node, determining (404), from the indication, that the UE, which is configured with conditional mobility procedures associated with at least one further network node, will not complete at least one of the conditional mobility procedures, and causing(406) the at least one further network node associated with the at least one of the conditional mobility procedures to release resources allocated for the at least one of the conditional mobility procedures.
Patent WO-2020231309-A1 (WO)
Inventor: EL ESSAILI ALI
IPC: H04W4/44
Filed: 2019-12-23
Abstract: Embodiments herein may e.g. provided a method performed by a vehicle to everything application enabler, VAE, client of a wireless device for using a service in a wireless communication network for vehicle to anything, V2X, wireless devices. The VAE client receives, from a V2X application specific client, a V2X message of a service with a service ID; and determines a network node for receiving an uplink V2X message based on the service ID. The VAE client further transmits the uplink V2X message to the determined network node with the service ID.
Patent WO-2020214074-A1 (WO)
Inventor: LÖFWALL TOMAS
IPC: H02K3/487
Filed: 2020-03-18
Abstract: A rotary electric machine comprising a rotor (1), a stator (2) disposed facing the rotor (1) in a radial direction and having a stator core (3) with a plurality of slots (4) extending in a radial direction from an inner periphery (5) of the stator core (3) towards an outer periphery (6) thereof, each slot (4) extending in an axial direction from a first axial end (7) of the stator core (3) to a second axial end (8) of the stator core (3), a stator winding (9) provided in said slots (4), wherein opposite axial ends of the winding (9) extend out of the slots (4) at said first and second axial ends of the stator core (3), and a cooling arrangement, comprising a cooling medium guide (10) arranged at at least one of said first and second end, said guide (10) comprising a cylindric element (11) provided in connection the inner periphery of the stator core (3) at said first or second end (7, 8). A plurality of fingers (12) are connected to the cylindric element (11) and each finger (12) of the plurality of fingers (12) extends radially inside the stator winding (9) in an axial direction from said first or second end (7, 8) of the stator core (3) into a respective slot (4) of the stator core (3).
Patent WO-2023128845-A1 (WO)
Title: Signalisation de synchronisation
Inventor: BALDEMAIR ROBERT
IPC: H04L5/00
Filed: 2021-12-31
Abstract: Un procédé est divulgué pour faire fonctionner un dispositif sans fil dans un réseau de communication sans fil, le procédé consistant à communiquer sur la base d'une signalisation de synchronisation reçue, la signalisation de synchronisation couvrant un intervalle de temps de signalisation ayant un nombre N1 d'intervalles de temps de symbole ou de symboles, N1 étant supérieur à 1 ; la signalisation de synchronisation comprenant, sur une intervalle de temps de symbole NP1 ou de symboles, une signalisation de synchronisation primaire, PSS ; la signalisation de synchronisation comprenant également, sur des intervalles de temps de symbole NS1 ou de symboles, une signalisation de synchronisation secondaire, SSS, NS1 étant supérieur ou égal à 2. La divulgation se rapporte également à des dispositifs et à des procédés associés.
Patent SG-55071-A1 (SG)
Title: Antipsychotic method
Inventor: BYMASTER FRANKLIN PORTER
IPC: A61K31/44
Filed: 1994-08-15
Abstract: The present invention relates to a novel method for treating a mammal suffering from or susceptible to schizophrenia and schizophreniform diseases comprising administering to said mammal an effective amount of a compound of formula (I), wherein Z<1> is oxygen or sulphur.
Patent SG-52536-A1 (SG)
Title: Sanitary napkin having convex upward shaped cross section
Inventor: BERGMAN CARL LOUIS
IPC: A61F13/15
Filed: 1994-12-15
Abstract: A sanitary napkin having an elastic member for foreshortening the sanitary napkin in the lateral direction. The elastic member is joined to the absorbent core of the sanitary napkin and acts to provide a convex upwardly shaped cross section. The cross section may be an inverted U-shaped or a W-shaped cross section. The core of the sanitary napkin may be decoupleable from the backsheet.
Patent SG-52568-A1 (SG)
Title: Method of tumor treatment
Inventor: BROWN MARTIN J
IPC: A61K33/243
Filed: 1994-09-19
Abstract: The present invention provides methods for treating mammalian cancer tumors, preferably solid tumors, comprising administering to a mammal in need of such treatment an effective amount of a 1,2,4-benzotriazine oxide as defined in Formula I or pharmacologically acceptable salts of said compound; and administering to the mammal from about one half hour to about twenty-four hours after administering the 1,2,4-benzotriazine oxide an effective amount of a chemotherapy agent to which the tumor is susceptible. The invention also provides kits for treatment of such tumors which comprise a chemotherapy agent and a cytotoxicity-enhancing amount of a 1,2,4-benzotriazine oxide as defined in Formula I.
Patent SG-144023-A1 (SG)
Title: Double plasma utbox
Inventor: RADO IONUT
Filed: 2007-10-12
Abstract: DOUBLE PLASMA UTBOX A method for bonding two substrates carried out in materials chosen from among semiconductor materials, said method implementing - A step to bond two substrates by thermal treatment - Plasma activation of the surface to be bonded for each substrate, the surfaces to be bonded of a first of the two substrates being comprised of an oxide layer, The method characterized in that the plasma activation of said oxide layer is carried out under an atmosphere containing oxygen, and the plasma activation of the surface to be bonded of the second substrate is carried out under an inert atmosphere.
Patent WO-2008091227-A1 (WO)
Title: Procédé et système pour une détection de début de chute
Inventor: NYAN MYO NAING
IPC: G08B21/04
Filed: 2008-01-22
Abstract: L'invention concerne un procédé et un système servant à détecter un début de chute. Le procédé comprend les étapes consistant à surveiller l'accélération au niveau de la cuisse d'une personne; surveiller l'accélération à la taille de la personne; surveiller l'orientation de la cuisse de la personne; et détecter le début de la chute si l'orientation de la cuisse dépasse une première valeur de seuil et une corrélation entre une variation de l'accélération de la cuisse et une variation de l'accélération de la taille dépasse une seconde valeur de seuil et une corrélation entre une variation de l'orientation de la cuisse et une variation du modèle de chute dépasse une troisième valeur de seuil.
Patent WO-2009139721-A1 (WO)
Title: Dispositif de suspension de colonne de production double
Inventor: TANG YEONG SOON
IPC: E21B33/047
Filed: 2008-05-12
Abstract: La présente invention concerne un dispositif de suspension de colonne de production double monté dans une tête de puits qui présente un alésage cylindrique avec un diamètre intérieur. Le dispositif de suspension de colonne de production double peut comprendre : un corps de dispositif de suspension cylindrique qui présente un diamètre extérieur inférieur au diamètre intérieur de l'alésage cylindrique; un premier mandrin situé à l’intérieur du corps de dispositif de suspension, le premier mandrin étant capable de transporter un premier fluide et comportant une première sortie au niveau d’une première élévation qui s’étend à travers le corps de dispositif de suspension cylindrique; un second mandrin situé à l’intérieur du corps de dispositif de suspension, le second mandrin étant capable de transporter un second fluide et possédant une seconde sortie qui s’étend à travers le corps du dispositif de suspension cylindrique sensiblement au niveau de la première élévation; et des moyens d’étanchéité entre le corps de dispositif de suspension et l'alésage cylindrique, les moyens d’étanchéité étant capables d’isoler le premier fluide du second fluide.
Patent SG-149771-A1 (SG)
Title: Vacuum insulated switchgear
Inventor: KUROGI TAKUYA
Filed: 2008-07-16
Abstract: VACUUM INSULATED SWITCHGEAR A vacuum insulated switchgear comprising a busbar compartment, in which phase-segregated double- break, three-position vacuum circuit breakers are disposed, feeder compartments disposed at both sides of the busbar compartment respectively, in each of which phase-segregated double-break, three-position vacuum circuit breakers are disposed, and the busbar compartment and the feeder compartments are aligned in a row, characterized in that, a second-phase insulated busbar is provided to connect one of fixed contacts of a second-phase breaker in the busbar compartment to a fixed contact of a second- phase breaker in one of the feeder compartments adjacent to the busbar compartment, a first-phase insulated busbar is provided to connect one of fixed contacts of a first-phase breaker in the busbar compartment to a fixed contact of a first-phase breaker in one of the feeder compartments adjacent to the busbar compartment, and the second-phase insulated busbar and the first-phase insulated busbar are disposed a different position in height each other. (Fig. 5)
Patent SG-158858-A1 (SG)
Title: Preparation of pharmaceutical salts of piperazine compounds
Inventor: WU WENXUE
Filed: 2006-01-05
Abstract: The present invention is generally directed to a process to directly prepare pharmaceutically acceptable salts enriched with respect to selected rotameric salts of a basic compound, by creative choice of an acid and a solvent medium. The process is particularly useful in preparing specific rotamers of pharmaceutically useful salts in desired preponderance of a rotamer.
Patent SG-164327-A1 (SG)
Title: Control of environmental conditioning devices
Inventor: T KANTHIMATHINATHAN
Filed: 2010-02-08
Abstract: A lighting installation comprises (a) a light, having a brightness, powered by an AC power supply, said AC power supply having a cycle of period t; and (b) a dimmer comprising a semiconductor switch operable to switch the light on and off. In normal operation the switch switches the light on and switches the light off, and the brightness of the light is altered by altering the switching on or the switching off so that the light is on for a longer or shorter portion x of the period t. A method of protecting the lighting installation comprises monitoring a load current passing through the switch to the light and, when the monitored current exceeds a threshold value, reducing the portion x of the period t for which the light is on, so that power dissipated in the switch is also reduced.
Patent SG-166092-A1 (SG)
Title: Information output device, medium and information input/output device
Inventor: YOSHIDA KENJI
Filed: 2006-08-02
Abstract: To achieve an information output device in which information of a medium disposed on a stage surface can be surely and efficiently read out, and a stage effect and a security are high. In the information output device, media are disposed on a stage surface in a state where the media are opposite to the stage surface, the media where dot patterns are printed on medium surfaces on the basis of a predetermined rule, the dot patterns are read by imaging units disposed in a space below the stage and converted into code values or coordinate values indicating the dot patterns from photographed images obtained by the imaging units, and information corresponding to the code values or the coordinate values is outputted. Further, light transmitting reading holes are respectively provided at a plurality of medium disposing locations on the stage surface, and the imaging units are disposed in the space below the stage corresponding the respective reading holes such that the imaging units photograph the medium surfaces of the media disposed on the reading holes. [Figure 5]
Patent SG-170073-A1 (SG)
Title: Long term treatment of hiv infection
Inventor: BAERT LIEVEN ELVIRE COLETTE
Filed: 2007-01-19
Abstract: This invention relates to the use of a parenteral formulation comprising an anti-virally effective amount of TMC278 or a pharmaceutically acceptable acid-addition salt thereof, and a carrier, for the manufacture of a medicament for the treatment of a subject being infected with HIV, wherein the formulation is to be administered intermittently at a time interval of at least one week.
Patent SG-171441-A1 (SG)
Title: Method for transferring particles
Inventor: NAUNHEIMER CHRISTOPHER
Filed: 2009-11-11
Abstract: Method and apparatus are provided for transferring particles from an upper zone through an intermediate zone to a lower zone. The transfer of particles between the zones through valveless conduits is regulated by varying the pressure of the intermediate zone and the flow rate of gas passing through the valveless conduits. A body within the lower zone is in particle communication with a valveless conduit and obstructs the particle flow within the lower zone.
Patent SG-172225-A1 (SG)
Title: Process for synthesis of amino-methyl tetraline derivatives
Inventor: DURKIN KIERAN
Filed: 2009-12-03
Abstract: Methods for producing a compound of formula (k1) or (k2) by reducing a dihydronapthalene amide compound of formula (i); with hydrogen gas in the presence of a ruthenium catalyst of formula (j1) or (j2); Ru(Z)2(L) = (j1), Ru(E)(E')(L)(D) = (j2); wherein m, n, Ar, Y, R1 E, E', D, Z and L are as defined herein.
Patent SG-183628-A1 (SG)
Title: Catheter tip device and method for manufacturing same
Inventor: NEIMAN BRAD JEFFREY
Filed: 2012-02-10
Abstract: A catheter tip device and methods for manufacturing of a catheter tip device. The device (10) comprises a transducer module (14) attached to a capsule (16), wherein the transducer module (14) comprises a carrier (26). The carrier (26) includes a recessed-die attach area (36), a lead area (32) having at least one groove (38) disposed therein and includes a barrier (42). The barrier (42) extends from the carrier (26) to partially circumscribe the recessed-die attach area (36). The methods of manufacturing the catheter tip device (10) involve the use of inserting the carrier (26) into the capsule (16).Figure 1
Patent SG-178793-A1 (SG)
Title: Vaccine therapy for choroidal neovascularization
Inventor: YASUHIRO TAMAKI
Filed: 2008-02-15
Abstract: The present inventors administered a peptide derived from VEGFR-2, which is known as one of the proteins involved in neovascularization, to model mice (A2/Kb transgenic mice)5 expressing human HLA-A*0201, and tested whether or not the peptide has vaccine effect. As a result, the present inventors successfully discovered that vaccination using this peptide as an antigen is effective for inhibition of choroid neovascularization, and thereby completed the present invention. More specifically, the present invention provides vaccines for treatment and/or prevention of diseases caused by choroid neovascularization (neovascular maculopathy),10 which contain a VEGFR-2-derived peptide as an active ingredient.NO SUITABLE FIGURE.
Patent SG-181871-A1 (SG)
Title: Active heave compensation with active damping control
Inventor: YUAN QINGHUI
Filed: 2010-12-20
Abstract: A damping control system (120) includes a first sensor (205) configured to detect movement of a vessel (100) and generate a first signal representing the vessel (100) movement and a second sensor (210) configured to detect movement of a cable (115) and generate a second signal representing the cable (115) movement. An actuator (215) is configured to dampen a force applied to a payload (110) during a force event. The force event is at least partially caused by the movement of the vessel (100) and the cable (115). A controller (220) is configured to identify the force event based at least in part on the first and second signals and control the actuator (215) during the force event to substantially dampen the force applied to the payload (110).
Patent SG-183656-A1 (SG)
Title: Anti condensation linear slot diffuser and bar grille in airconditional
Inventor: NGAN KHAY SENG
Filed: 2012-07-16
Abstract: ANTI CONDENSATION LINEAR SLOTS DIFFUSER AND BAR GRILLE This invention relates to a method and material for anti-condensation by temperature control in air-conditiner. And then, the method is to have a structure in the air-conditioner's outlet with 90% of Flame Retardant (WPC)Wood Plastic Composite and 10% of Flame Redardant Rubber Insulation instead of the normal meterial of the normal material of 98% aluminium and 2% metal. The method and material could be used to control the temperature difference between the air-conditiner's outside and inside to anti-condense the water into water dropsin the outlet's of air-conditioner by forming the water into the surface of the material.Figure 5
Patent SG-186075-A1 (SG)
Title: Dosing unit for a powder dispenser
Inventor: HU RUGUO
Filed: 2011-06-06
Abstract: The invention concerns a dosing unit for a powder dispenser comprising two dosing chambers (2,3) each chamber comprising : - one upstream inlet (21, 31) and one downstream outlet (22, 32), - an upstream means (23, 33) for opening and closing the inlet, - a downstream means (24, 34) for opening and closing the outlet, the upstream means (23, 33) closing the inlet (21, 31) when the downstream means (24, 34) opens the outlet (22, 32) and reciprocally, wherein the upstream means (23) of the first chamber closes the first chamber (2) when the upstream means (33) of the second chamber opens the second chamber (3) and reciprocally.
Patent SG-186109-A1 (SG)
Title: Methods of treating bladder cancer
Inventor: DESAI NEIL P
Filed: 2011-05-20
Abstract: The present invention provides methods and compositions for treating bladder cancer, including metastatic bladder cancer and non-muscle-invasive bladder cancer, by administering a composition comprising nanoparticles that comprise a taxane and an albumin.
Patent SG-187884-A1 (SG)
Title: Method for concentrating an aqueous hydrogen peroxide solution
Inventor: EICKHOFF HUBERTUS
Filed: 2011-07-29
Abstract: Method for concentrating an aqueous hydrogen peroxidesolutionAbstract:In a process for concentrating aqueous hydrogen peroxide solution to give two hydrogen peroxide streams of different concentration in an apparatus comprising apreevaporator (1), a distillation column (2) and a vapour compressor (3), in which the aqueous hydrogen peroxide solution to be concentrated (4) is continuously fed into the preevaporator, vapour (5) produced by evaporation in the preevaporator is fed tothe distillation column, bottom product (6) obtained in the preevaporator is withdrawn as a first concentrated hydrogen peroxide stream (7), vapour (8) produced in the distillation column is withdrawn from the distillation column at the top of the column,compressed by means of the vapour compressor and used for heating the preevaporator and the bottom product (9) obtained in the distillation column is withdrawn as a second concentrated hydrogen peroxide stream (10), two concentrated hydrogen peroxide solutions havingdiffering concentrations in the range from 50 to 70% by weight of hydrogen peroxide can be produced at the same time in a freely selectable ratio by feeding part of the bottom product obtained in the preevaporator in liquid form to the distillation column.(Fig. 2)
Patent SG-188985-A1 (SG)
Title: Piperidinyl-substituted lactams as gpr119 modulators
Inventor: AICHER THOMAS DANIEL
Filed: 2011-09-15
Abstract: Compounds of Formula (I) and pharmaceutically acceptable salts thereof in which X1, X2, L, R3, R4, R5, R7 and n have the meanings given in the specification, are modulators of GPR119 and are useful in the treatment or prevention of diseases such as such as, but not limited to, type 2 diabetes, diabetic complications, symptoms of diabetes, metabolic syndrome, obesity, dyslipidemia, and related conditions.
Patent SG-190028-A1 (SG)
Title: Graphene-coated diamond particles, compositions and intermediate structures comprising same, and methods of forming graphene-coated diamond particles and polycrystalline compacts
Inventor: CHAKRABORTY SOMA
IPC: B22F1/18
Filed: 2011-10-27
Abstract: Coated diamond particles have solid diamond cores and at least one graphene layer. Methods include coating diamond particles with a charged species and coating the diamond particles with a graphene layer. A composition includes a substance and a plurality of coated diamond particles dispersed within the substance. Each coated diamond particle has a diamond core and at least one graphene layer formed over at least a portion of the diamond core.
Patent SG-190210-A1 (SG)
Title: Pharmaceutical compositions
Inventor: CAO YU
Filed: 2011-12-01
Abstract: The present invention relates to a pharmaceutical composition for the oral administration of a therapeutic compound of formula (I), which comprises granules that comprise at least therapeutic compound of formula (I) (see below), particularly 2-Methyl-2-[4-(3-methyl-2-oxo-8- quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile or 8-(6-methoxy-pyridin-3-yl)-3-methyl-1-(4-piperazin-1-yl-3-trifluoromethyl-phenyl)-1,3-dihydro-imidazo[4,5-c]quinolin-2-one, or a tautomer thereof, or a pharmaceutically acceptable salt, or a hydrate or solvate thereof; at least one non-ionic surfactant that is Vitamin E-TPGS in an amount ranging from about 15 to about 80% by weight of the composition; and at least one a dissolution enhancing agent selected from polyethylene glycol, polyethylene oxide, and any combination of the foregoing. The present invention also relates to processes for making such pharmaceutical compositions; a kit comprising such pharmaceutical composition and the instructions provide that the pharmaceutical composition may be taken immediately to about thirty minutes after the consumption of food; and related uses and methods of treatment.
Patent SG-190233-A1 (SG)
Title: Tooth preparation guide device and method of preparing tooth for dental prosthesis
Inventor: KWON OH-DAL
IPC: A61C5/77
Filed: 2011-11-17
Abstract: Dental preparation uses a tooth preparation guide custom-made for fitting with teeth of a patient. The preparation guide includes one or more guide channels for guiding a cutting tool. The preparation guide enables modification of the teeth as planned with high level of precision. A dental prosthesis for installing onto prepared teeth of the patient is provided before preparation of the teeth. The prosthesis includes features that are complementary to the prepared teeth. The prosthesis can be installed immediately after preparing the teeth using the preparation guide. With the high level of accuracy and precision in the preparation of teeth, no modification of the prosthesis would be needed for installation.